Ameritas Advisory Services, LLC

Position in NVO — Novo Nordisk A S

CIK 1901275 LINCOLN, NE

Position in NVO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,320,008

+$1,541,460 QoQ

Shares Held

48,394

+128.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#354

of 1,348 holders

Holding Since

Mar 2023

14 quarters on record

Healthcare · as of Jun 30, 2026

Ameritas Advisory Services, LLC holds $48,964,363 across 14 Drug Manufacturers - General names. NVO ranks #6 (4.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	13,778	$16,525,747
2	ABBV	AbbVie Inc.	32,773	$8,246,997
3	JNJ	Johnson & Johnson	25,667	$6,518,647
4	AMGN	Amgen Inc	14,119	$5,112,772
5	MRK	Merck & Co., Inc.	29,071	$3,735,623
6	NVO	Novo Nordisk A S This page	48,394	$2,320,008
7	PFE	Pfizer Inc	88,492	$2,130,887
8	AZN	Astrazeneca PLC	6,076	$1,152,131

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,320,008	48,394	+128.4%	Shares	Sole	2026-08-14
2026-03-31	$778,548	21,185	+45.2%	Shares	Sole	2026-05-12
2025-12-31	$742,390	14,591	-24.7%	Shares	Sole	2026-02-04
2025-09-30	$1,075,507	19,382	+289.4%	Shares	Sole	2025-11-06
2025-06-30	$343,512	4,977	+41.1%	Shares	Sole	2025-07-21
2025-03-31	$244,984	3,528	-67.9%	Shares	Sole	2025-04-25
2024-12-31	$946,220	11,000	+453.3%	Shares	Sole	2025-01-15
2024-09-30	$236,711	1,988	-81.8%	Shares	Sole	2024-10-30
2024-06-30	$1,558,007	10,915	-2.7%	Shares	Sole	2024-07-29
2024-03-31	$1,440,904	11,222	+185.0%	Shares	Sole	2024-05-14
2023-12-31	$407,386	3,938	-64.6%	Shares	Sole	2024-02-14
2023-09-30	$1,010,616	11,113	+157.8%	Shares	Sole	2023-11-13
2023-06-30	$697,487	4,310	+0.8%	Shares	Sole	2023-07-25
2023-03-31	$680,641	4,277	—	Shares	Sole	2023-04-28
No filing history on record for this holder in this stock.